Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Discovery of potent, selective and orally bioavailable imidazo[1,5-a]pyrazine derived ACK1 inhibitors.

Jin M, Wang J, Kleinberg A, Kadalbajoo M, Siu KW, Cooke A, Bittner MA, Yao Y, Thelemann A, Ji Q, Bhagwat S, Mulvihill KM, Rechka JA, Pachter JA, Crew AP, Epstein D, Mulvihill MJ.

Bioorg Med Chem Lett. 2013 Feb 15;23(4):979-84. doi: 10.1016/j.bmcl.2012.12.042. Epub 2012 Dec 21.

PMID:
23317569
2.

Temporal quantitation of mutant Kit tyrosine kinase signaling attenuated by a novel thiophene kinase inhibitor OSI-930.

Petti F, Thelemann A, Kahler J, McCormack S, Castaldo L, Hunt T, Nuwaysir L, Zeiske L, Haack H, Sullivan L, Garton A, Haley JD.

Mol Cancer Ther. 2005 Aug;4(8):1186-97.

3.

Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells.

Thelemann A, Petti F, Griffin G, Iwata K, Hunt T, Settinari T, Fenyo D, Gibson N, Haley JD.

Mol Cell Proteomics. 2005 Apr;4(4):356-76. Epub 2005 Jan 17.

4.

[Ventricular cardiac arrhythmia in patients with terminal renal failure and chronic dialysis].

Grossmann R, Thelemann A, Albert FW, Bergbauer M, Ricken D.

Med Klin (Munich). 1988 Nov 11;83(22):735-9. German. No abstract available.

PMID:
2467182

Supplemental Content

Loading ...
Support Center